Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: Shareholder meeting in october 2007
From the 10K regarding the meeting:

"DOCUMENTS INCORPORATED BY REFERENCE
 
Certain information required to be disclosed in Part III of this report is incorporated by reference from the registrant’s definitive Proxy Statement for the 2007 annual meeting of shareholders, which will be held in October 2007 and which proxy statement will be filed not later than 120 days after the end of the fiscal year covered by this report."
Share
New Message
Please login to post a reply